Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Novel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease.
Zhou J, Fonseca MI, Kayed R, Hernandez I, Webster SD, Yazan O, Cribbs DH, Glabe CG, Tenner AJ
J Neuroinflammation 2005, 2:28
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.
Patton RL, Kalback WM, Esh CL, Kokjohn TA, Van Vickle GD, Luehrs DC, Kuo YM, Lopez J, Brune D, Ferrer I, Masliah E, Newel AJ, Beach TG, Castaño EM, Roher AE
Am J Pathol 2006 Sep, 169:1048-63
 [PubMed Central] [PubMed] [Related articles]
2.
Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.
He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C, Staufenbiel M, Li R, Shen Y
J Cell Biol 2007 Aug 27, 178:829-41
 [PubMed Central] [PubMed] [Related articles]
3.
Impact of amyloid imaging on drug development in Alzheimer's disease.
Mathis CA, Lopresti BJ, Klunk WE
Nucl Med Biol 2007 Oct, 34:809-22
 [PubMed Central] [PubMed] [Related articles]
4.
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ
J Neurochem 2008 Sep, 106:2080-92
 [PubMed Central] [PubMed] [Related articles]
5.
Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives.
Trouche SG, Asuni A, Rouland S, Wisniewski T, Frangione B, Verdier JM, Sigurdsson EM, Mestre-Francés N
Vaccine 2009 Feb 11, 27:957-64
 [PubMed Central] [PubMed] [Related articles]
6.
The role of the anaphylatoxins in health and disease.
Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, Köhl J
Mol Immunol 2009 Sep, 46:2753-66
 [PubMed Central] [PubMed] [Related articles]
7.
Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.
Sigurdsson EM
J Alzheimers Dis 2008 Oct, 15:157-68
 [PubMed Central] [PubMed] [Related articles]
8.
Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.
Boutajangout A, Goni F, Knudsen E, Schreiber F, Asuni A, Quartermain D, Frangione B, Chabalgoity A, Wisniewski T, Sigurdsson EM
J Alzheimers Dis 2009 Dec, 18:961-72
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 3 articles in BioMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.